{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:33:15Z","timestamp":1776454395401,"version":"3.51.2"},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,4,23]]},"DOI":"10.1253\/circj.cj-20-0966","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T22:09:47Z","timestamp":1617142187000},"page":"595-603","source":"Crossref","is-referenced-by-count":6,"title":["Medication Adherence and Clinical Outcome of Fixed-Dose Combination vs. Free Combination of Angiotensin Receptor Blocker and Statin"],"prefix":"10.1253","volume":"85","author":[{"given":"Jung Min","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hwa","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jeong","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Digital Health, SAIHST, Sungkyunkwan University"},{"name":"Health Promotion Center, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University"},{"name":"Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hayes SN, Kim CESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, et al. Spontaneous coronary artery dissection: Current state of the science: A scientific statement from the American Heart Association. <i>Circulation<\/i> 2018; 137: e523\u2013e557.","DOI":"10.1161\/CIR.0000000000000564"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: National health and nutrition examination surveys 1988\u20132010. <i>Circulation<\/i> 2013; 128: 29\u201341.","DOI":"10.1161\/CIRCULATIONAHA.112.000500"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Burnier M, Egan BM. Adherence in hypertension. <i>Circ Res<\/i> 2019; 124: 1124\u20131140.","DOI":"10.1161\/CIRCRESAHA.118.313220"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Colantonio LD, Rosenson RS, Deng L, Monda KL, Dai Y, Farkouh ME, et al. Adherence to statin therapy among US adults between 2007 and 2014. <i>J Am Heart Assoc<\/i> 2019; 8: e010376.","DOI":"10.1161\/JAHA.118.010376"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease. <i>JAMA Cardiol<\/i> 2019; 4: 206\u2013213.","DOI":"10.1001\/jamacardio.2018.4936"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. DiPette DJ, Skeete J, Ridley E, Campbell NRC, Lopez-Jaramillo P, Kishore SP, et al. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. <i>J Clin Hypertens<\/i> 2018; 21: jch.13426.","DOI":"10.1111\/jch.13426"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure\u2013lowering medication in ambulatory care?: Systematic review of randomized controlled trials. <i>Arch Intern Med<\/i> 2004; 164: 722\u2013732.","DOI":"10.1001\/archinte.164.7.722"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. <i>Eur Heart J<\/i> 2018; 39: 3021\u20133104.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease. <i>Circulation<\/i> 2019; 140: e177\u2013e232.","DOI":"10.1016\/j.jacc.2019.03.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. <i>PLoS Med<\/i> 2007; 4: e296.","DOI":"10.1371\/journal.pmed.0040296"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Leslie SR, Gwadry-Sridhar F, Thiebaud P, Patel BV. Calculating medication compliance, adherence and persistence in administrative pharmacy claims databases. <i>Pharm Program<\/i> 2008; 1: 13\u201319.","DOI":"10.1179\/175709208X334614"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: Terminology and definitions. <i>Value Heal<\/i> 2008; 11: 44\u201347.","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kolandaivelu K, Leiden BB, O\u2019Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. <i>Eur Heart J<\/i> 2014; 35: 3267\u20133276.","DOI":"10.1093\/eurheartj\/ehu364"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Charlson ME, Pompei P, Ales KL, MacKenzie R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. <i>J Chronic Dis<\/i> 1987; 20: 85\u201391.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, St\u00fcrmer T. Propensity score methods to control for confounding in observational cohort studies: A statistical primer and application to endoscopy research. <i>Gastrointest Endosc<\/i> 2019; 90: 360\u2013369.","DOI":"10.1016\/j.gie.2019.04.236"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. de Boer SPM, Lenzen MJ, Oemrawsingh RM, Simsek C, Duckers HJ, van der Giessen WJ, et al. Evaluating the \u201call-comers\u201d design: A comparison of participants in two \u201call-comers\u201d PCI trials with non-participants. <i>Eur Heart J<\/i> 2011; 32: 2161\u20132167.","DOI":"10.1093\/eurheartj\/ehr126"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): A pragmatic, cluster-randomised trial. <i>Lancet<\/i> 2019; 394: 672\u2013683.","DOI":"10.1016\/S0140-6736(19)31791-X"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Webster R, Salam A, De Silva HA, Selak V, Stepien S, Rajapakse S, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka a randomized clinical trial. <i>JAMA<\/i> 2018; 320: 566\u2013579.","DOI":"10.1001\/jama.2018.10359"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, et al. Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). <i>Hypertension<\/i> 2018; 71: 681\u2013690.","DOI":"10.1161\/HYPERTENSIONAHA.117.10662"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cifu AS, Davis AM. Prevention, detection, evaluation, and management of high blood pressure in adults. <i>JAMA<\/i> 2017; 318: 2132\u20132134.","DOI":"10.1001\/jama.2017.18706"},{"key":"21","unstructured":"21. Nickenig G. Should angiotensin II receptor blockers and statins be combined? <i>Circulation<\/i> 2004; 110: 1013\u20131020."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lee HY, Sakuma I, Ihm SH, Goh CW, Koh KK. Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease. <i>Circ J<\/i> 2014; 78: 281\u2013287.","DOI":"10.1253\/circj.CJ-13-1494"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Messerli FH, Bangalore S. Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction. <i>Circulation<\/i> 2017; 135: 2085\u20132087.","DOI":"10.1161\/CIRCULATIONAHA.116.025950"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gautam CS, Saha L. Fixed dose drug combinations (FDCs): Rational or irrational: A view point. <i>Br J Clin Pharmacol<\/i> 2008; 65: 795\u2013796.","DOI":"10.1111\/j.1365-2125.2007.03089.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. <i>JAMA<\/i> 2014; 312: 799\u2013808.","DOI":"10.1001\/jama.2014.10057"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Grimmsmann T, Himmel W. Comparison of therapy persistence for fixed versus free combination antihypertensives: A retrospective cohort study. <i>BMJ Open<\/i> 2016; 6: 11650.","DOI":"10.1136\/bmjopen-2016-011650"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Dickerman BA, Garc\u00eda-Alb\u00e9niz X, Logan RW, Denaxas S, Hern\u00e1n MA. Avoidable flaws in observational analyses: An application to statins and cancer. <i>Nat Med<\/i> 2019; 25: 1601\u20131606.","DOI":"10.1038\/s41591-019-0597-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. <i>Circulation<\/i> 2009; 119: 3028\u20133035.","DOI":"10.1161\/CIRCULATIONAHA.108.768986"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, et al. Validity of medication adherence self-reports in adults with type 2 diabetes. <i>Diabetes Care<\/i> 2013; 36: 831\u2013837.","DOI":"10.2337\/dc12-0410"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/5\/85_CJ-20-0966\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T03:36:47Z","timestamp":1619235407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/5\/85_CJ-20-0966\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-0966","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}